Novo Nordisk A/S – Share repurchase programme

Novo Nordisk A/S – Share repurchase programme

Bagsværd, Denmark, 2 September 2019 – On 9 August 2019, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 15 billion to be executed during a 12-month period beginning 1 February 2019.

Under the programme initiated 9 August 2019, Novo Nordisk will repurchase B shares for an amount up to DKK 2.6 billion in the period from 9 August 2019 to 30 October 2019.

Since the announcement as of 26 August 2019, the following transactions have been made:

The details for each transaction made under the share repurchase programme are published on novonordisk.com.

Transactions related to Novo Nordisk’s incentive programmes have resulted in a net transfer from Novo Nordisk of 150 B shares in the period from 26 August 2019 to 30 August 2019. The shares in these transactions were not part of the Safe Harbour repurchase programme.

With the transactions stated above, Novo Nordisk owns a total of 32,614,044 B shares of DKK 0.20, corresponding to 1.4% of the share capital, as treasury shares. The total amount of A and B shares in the company is 2,400,000,000 including treasury shares.

Novo Nordisk expects to repurchase B shares for an amount up to DKK 15 billion during a 12-month period beginning 1 February 2019. As of 30 August 2019, Novo Nordisk has since 1 February 2019 repurchased a total of 25,455,012 B shares at an average share price of DKK 327.94 per B share equal to a transaction value of DKK 8,347,592,054.

Further information

Company announcement no. 51 / 2019

Attachment

• CA190902_Safe_Harbour